Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Masur

Showing results (191-200 of 292) with videos related to

Pageof 30
Sort By:
Annals of Internal Medicine|March 1, 1988
Intestinal infections in patients with the acquired immunodeficiency syndrome (AIDS). Etiology and response to therapyP D Smith, H C Lane, V J Gill, et al.
HIV Medicine|March 14, 2007
Cytochrome P450 2B6 (CYP2B6) G516T influences nevirapine plasma concentrations in HIV-infected patients in UgandaS R Penzak, G Kabuye, P Mugyenyi, et al.
Journal of Viral Hepatitis|February 4, 2016
Achieving sustained virologic response after interferon-free hepatitis C virus treatment correlates with hepatic interferon gene expression changes independent of cirrhosisE G Meissner, A Kohli, K Virtaneva, et al.
The New England Journal of Medicine|May 27, 1993
Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDSW Hughes, G Leoung, F Kramer, et al.
The Journal of Infectious Diseases|May 1, 1987
Potent effect of trimetrexate, a lipid-soluble antifolate, on Toxoplasma gondiiJ A Kovacs, C J Allegra, B A Chabner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2000
An overview of the 1999 US Public Health Service/Infectious Diseases Society of America guidelines for preventing opportunistic infections in human immunodeficiency virus-infected personsJ E Kaplan, H Masur, K K Holmes, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1987
Mycobacterium avium-M. intracellulare and Acquired Immunodeficiency SyndromeE Wolinsky, C R Horsburgh, D L Cohn, et al.
Radiology|March 1, 1990
Thin-walled cavities, cysts, and pneumothorax in Pneumocystis carinii pneumonia: further observations with histopathologic correlationI M Feurestein, A Archer, J M Pluda, et al.
The New England Journal of Medicine|November 2, 1989
Reversible cardiac dysfunction associated with interferon alfa therapy in AIDS patients with Kaposi's sarcomaL R Deyton, R E Walker, J A Kovacs, et al.
The American Journal of Medicine|March 1, 1987
Combination chemotherapy of disseminated Kaposi's sarcoma in patients with the acquired immune deficiency syndromeE P Gelmann, D Longo, H C Lane, et al.
Pageof 30

Showing results (191-200 of 292) with videos related to

Sort By:
Pageof 30
Annals of Internal Medicine|March 1, 1988
Intestinal infections in patients with the acquired immunodeficiency syndrome (AIDS). Etiology and response to therapyP D Smith, H C Lane, V J Gill, et al.
HIV Medicine|March 14, 2007
Cytochrome P450 2B6 (CYP2B6) G516T influences nevirapine plasma concentrations in HIV-infected patients in UgandaS R Penzak, G Kabuye, P Mugyenyi, et al.
Journal of Viral Hepatitis|February 4, 2016
Achieving sustained virologic response after interferon-free hepatitis C virus treatment correlates with hepatic interferon gene expression changes independent of cirrhosisE G Meissner, A Kohli, K Virtaneva, et al.
The New England Journal of Medicine|May 27, 1993
Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDSW Hughes, G Leoung, F Kramer, et al.
The Journal of Infectious Diseases|May 1, 1987
Potent effect of trimetrexate, a lipid-soluble antifolate, on Toxoplasma gondiiJ A Kovacs, C J Allegra, B A Chabner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2000
An overview of the 1999 US Public Health Service/Infectious Diseases Society of America guidelines for preventing opportunistic infections in human immunodeficiency virus-infected personsJ E Kaplan, H Masur, K K Holmes, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1987
Mycobacterium avium-M. intracellulare and Acquired Immunodeficiency SyndromeE Wolinsky, C R Horsburgh, D L Cohn, et al.
Radiology|March 1, 1990
Thin-walled cavities, cysts, and pneumothorax in Pneumocystis carinii pneumonia: further observations with histopathologic correlationI M Feurestein, A Archer, J M Pluda, et al.
The New England Journal of Medicine|November 2, 1989
Reversible cardiac dysfunction associated with interferon alfa therapy in AIDS patients with Kaposi's sarcomaL R Deyton, R E Walker, J A Kovacs, et al.
The American Journal of Medicine|March 1, 1987
Combination chemotherapy of disseminated Kaposi's sarcoma in patients with the acquired immune deficiency syndromeE P Gelmann, D Longo, H C Lane, et al.
Pageof 30